6-mercaptopurine hydrate

6-Mercaptopurine hydrate (6-Mercaptopurine monohydrate) is a Nucleoside Metabolic Inhibitor. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.

7-Methyl-6-mercaptopurine (7-Methyl-6-thiopurine) is an inhibitor of PRPP aminotransferase, inhibits IMP metabolism and prevents purine, DNA and RNA synthesis.

D-Fructose-6-phosphate (sodium salt hydrate) is a sugar intermediate in the glycolytic pathway produced by the isomerization of glucose 6-phosphate by glucose phosphate isomerase, and is used in cancer research.

6-Mercaptopurine (6-MP) is an antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.

D-Mannose-6-Phosphate sodium salt hydrate is a multifunctional monosaccharide used in the study of metabolism, lysosomal delivery and cancer.

MEK-IN-6 hydrate (compound 69), a MEK inhibitor, exhibits an IC50 value of 2 nM in A375 cells [1].

Trehalose 6-phosphate potassium salt hydrate (α,α-Trehalose 6-phosphate potassium salt hydrate) is a Trehalose derivative, an intermediate in trehalose biosynthesis, and an important signaling metabolite in plants. It can regulate root branching through the master kinase SNF1-related kinase-1 (SnRK1) and rapamycin target (TOR).